(Q37827971)

23 August 2017

1 reference

title

Liver fluke isolates: a question of provenance (English)

1 reference

23 August 2017

1 reference

I Fairweather

1

1 reference

23 August 2017

21 December 2010

1 reference

23 August 2017

Veterinary Parasitology

1 reference

23 August 2017

176

1 reference

23 August 2017

1

1 reference

23 August 2017

1-8

1 reference

Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes

23 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Lack of reversion in triclabendazole-resistant Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Fasciola hepatica: surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole ('Valbazen').

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Activity of closantel against adult triclabendazole-resistant Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Comparison of two assays, a faecal egg count reduction test (FECRT) and a coproantigen reduction test (CRT), for the diagnosis of resistance to triclabendazole in Fasciola hepatica in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

The occurrence and significance of triploidy in the liver fluke, Fasciola hepatica.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

An experimental study on triclabendazole resistance of Fasciola hepatica in sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Electron microscopical study to assess the in vitro effects of the synthetic trioxolane OZ78 against the liver fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Fasciola hepatica: Histology of the testis in egg-producing adults of several laboratory-maintained isolates of flukes grown to maturity in cattle and sheep and in flukes from naturally infected hosts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Efficacy of an injectable combination anthelmintic (nitroxynil+clorsulon+ivermectin) against early immature Fasciola hepatica compared to triclabendazole combination flukicides given orally or topically to cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Fasciola hepatica: tegumental alterations in adult flukes following in vitro and in vivo administration of artesunate and artemether

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Fasciola hepatica: Surface tegumental responses to in vitro and in vivo treatment with the experimental fasciolicide OZ78.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Artesunate and artemether are effective fasciolicides in the rat model and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Efficacy of nitroxynil against Fasciola hepatica resistant to triclabendazole in a naturally infected sheep flock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Surface changes in adult Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Ultrastructural changes to the tegumental system and the gastrodermal cells in adult Fasciola hepatica following in vivo treatment with the experimental fasciolicide, compound alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Fasciola hepatica: disruption of spermatogenesis by the fasciolicide compound alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Fasciola hepatica: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (Trodax).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Morphological response of triclabendazole-susceptible and triclabendazole-resistant isolates of Fasciola hepatica to treatment in vitro with nitroxynil (Trodax).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Transmission electron microscope study of the ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo drug treatment with clorsulon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

A scanning electron microscope study on the route of entry of clorsulon into the liver fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Ultrastructural observations on oral ingestion and trans-tegumental uptake of clorsulon by the liver fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Glutathione S-transferases as markers of salicylanilide resistance in isolates of Fasciola hepatica.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

The comparative efficacy of four anthelmintics against a natural acquired Fasciola hepatica infection in hill sheep flock in the west of Ireland.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Triclabendazole-resistant Fasciola hepatica: beta-tubulin and response to in vitro treatment with triclabendazole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Fasciola hepatica expresses multiple alpha- and beta-tubulin isotypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Seasonal differences in the efficacy of pour-on formulations of triclabendazole and ivermectin or abamectin against late immature liver fluke (Fasciola hepatica) in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Physiological and morphological effects of genistein against the liver fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

A transmission electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Tegumental surface changes in adult Fasciola hepatica in response to treatment in vivo with triclabendazole in the sheep host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Disruption of egg formation by Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

Stage-specific differences in fecundity over the life-cycle of two characterized isolates of the liver fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.12.011

10.1016/J.VETPAR.2010.12.011

7 January 2021

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21227593